CN103656530B - A kind of Chinese medicine composition for the treatment of cyclomastopathy - Google Patents

A kind of Chinese medicine composition for the treatment of cyclomastopathy Download PDF

Info

Publication number
CN103656530B
CN103656530B CN201310718920.2A CN201310718920A CN103656530B CN 103656530 B CN103656530 B CN 103656530B CN 201310718920 A CN201310718920 A CN 201310718920A CN 103656530 B CN103656530 B CN 103656530B
Authority
CN
China
Prior art keywords
rhizoma
parts
chinese medicine
cyclomastopathy
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310718920.2A
Other languages
Chinese (zh)
Other versions
CN103656530A (en
Inventor
刘永秋
胡崇惜
傅晓倩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310718920.2A priority Critical patent/CN103656530B/en
Publication of CN103656530A publication Critical patent/CN103656530A/en
Application granted granted Critical
Publication of CN103656530B publication Critical patent/CN103656530B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a kind of Chinese medicine composition for the treatment of cyclomastopathy, be made up of according to weight fraction following component: Radix Curcumae 45-55 part, Herba Leonuri 45-55 part, Cortex Moutan 45-55 part, Sanguis Draxonis 45-55 part, Lignum Dalbergiae Odoriferae 45-55 part, Rhizoma Arisaematis 25-35 part, Rhizoma Typhonii 25-35 part, Rhizoma Dioscoreae Bulbiferae 25-35 part, Herba Ardisiae Japonicae 25-35 part, Rhizoma Curcumae Longae 25-35 part, Rhizoma Polygoni Cuspidati 5-15 part, Rhizoma Osmundae 5-15 part, Cornu Saigae Tataricae 5-15.The Chinese medicine composition for the treatment of cyclomastopathy of the present invention, formulated according to theory of Chinese medical science, promoting blood circulation to remove blood stasis, eliminating stagnation, pain relieving, heat-clearing and toxic substances removing, each taste Chinese medicine combines according to monarch, plays maximum drug effect, Chinese medicine preparation, toxic and side effects is little, and cost is low, treating both the principal and secondary aspects of a disease.

Description

A kind of Chinese medicine composition for the treatment of cyclomastopathy
Technical field
The present invention relates to field of traditional Chinese, particularly a kind of Chinese medicine composition for the treatment of cyclomastopathy.
Background technology
Cyclomastopathy refers to breast epithelium and proliferation of fibrous tissue, mammary gland tissue conduit and newborn lobule degeneration structurally and the growth of Progressive symmetric erythrokeratodermia connective tissue, and its pathogenic factor is mainly due to endocrine hormone imbalance.
The clinical manifestation of cyclomastopathy mainly contains: 1. mastalgia, and be often distending pain or twinge, can involve one or both sides breast, lay particular stress on common with side, pain severe patient can not be touched, and even affects daily life and work.Pain, also can to Ipsilateral axillary fossa, the breast side of body or the radiation of shoulder back based on lump in breast place; Some then shows as sore nipples or itches.Mastalgia Chang Yuyue premenstrual a couple of days occurs or increases the weight of, and after passing through, pain obviously alleviates or disappears; Pain also can fluctuate with emotion changes.This pain relevant with menstrual cycle and emotion changes is the main feature of cyclomastopathy clinical manifestation.2. lump in breast, lump can be sent out in one-sided or bilateral breast, single or multiple, is apt to occur in the outside upper quadrant of breast, is also found in other quadrants.Lump shape has sheet bulk, nodositas, streak, graininess etc., is wherein common with sheet bulk.Lump border is not obvious, and quality is medium or slightly firmly tough, movable good, with surrounding tissue without adhesion, often has tenderness.Tumor size differs, and little person is large as foxtail millet grain, and large person can exceed 3 ~ 4cm.Lump in breast also has the feature changed with menstrual cycle, and the moon, premenstrual lump increased hardening, mass reduction deliquescing after menstrual onset.3. nipple discharge, can there are nipple discharge in small number of patients, be spontaneous discharge, also have few person extrude nipple have courageous and upright discharge or milky to overflow as seen body overflows, olive drab(O.D) or brown slurry discharge.4. menoxenia, this patient can doublely to see before and after menstruation irregularly, amount less or color light, can dysmenorrhea be accompanied.5. feelings will changes, the smooth or susceptible to lose temper due to restlessness of the normal emotion will of patient, whenever angry, psychentonia or tired postemphasis.
Summary of the invention
For the defect existed in prior art, the object of the present invention is to provide a kind of Chinese medicine composition for the treatment of cyclomastopathy.
Technical scheme of the present invention is as follows:
Treat a Chinese medicine composition for cyclomastopathy, be made up of according to weight fraction following component:
Radix Curcumae 45-55 part, Herba Leonuri 45-55 part, Cortex Moutan 45-55 part, Sanguis Draxonis 45-55 part, Lignum Dalbergiae Odoriferae 45-55 part, Rhizoma Arisaematis 25-35 part, Rhizoma Typhonii 25-35 part, Rhizoma Dioscoreae Bulbiferae 25-35 part, Herba Ardisiae Japonicae 25-35 part, Rhizoma Curcumae Longae 25-35 part, Rhizoma Polygoni Cuspidati 5-15 part, Rhizoma Osmundae 5-15 part, Cornu Saigae Tataricae 5-15.
On the basis of such scheme, a kind of Chinese medicine composition for the treatment of cyclomastopathy, is made up of according to weight fraction following component:
Radix Curcumae 50 parts, Herba Leonuri 50 parts, Cortex Moutan 50 parts, Sanguis Draxonis 50 parts, Lignum Dalbergiae Odoriferae 50 parts, Rhizoma Arisaematis 30 parts, Rhizoma Typhonii 30 parts, Rhizoma Dioscoreae Bulbiferae 30 parts, Herba Ardisiae Japonicae 30 parts, 30 parts, Rhizoma Curcumae Longae, Rhizoma Polygoni Cuspidati 10 parts, Rhizoma Osmundae 10 parts, Cornu Saigae Tataricae 10.
Chinese medicine composition of the present invention, in prescription, Radix Curcumae promoting blood circulation and stopping pain, removing heat from blood clear away heart-fire, Herba Leonuri blood circulation promoting and blood stasis dispelling, Cortex Moutan clearing away heat and cooling blood, promoting blood circulation to remove blood stasis, Sanguis Draxonis promoting blood circulation to remove blood stasis, Lignum Dalbergiae Odoriferae promoting blood circulation to remove blood stasis, are monarch drug altogether; Rhizoma Arisaematis reducing swelling and alleviating pain, eliminating stagnation, Rhizoma Typhonii detoxicating and resolving stagnation of pathogens, Rhizoma Dioscoreae Bulbiferae eliminating stagnation disappears wart, and Herba Ardisiae Japonicae, Rhizoma Curcumae Longae inducing menstruation to relieve menalgia are ministerial drug altogether; Rhizoma Polygoni Cuspidati heat-clearing and toxic substances removing, analgesic therapy of invigorating blood circulation, Rhizoma Osmundae, Cornu Saigae Tataricae heat-clearing and toxic substances removing, three medicines are adjuvant drug altogether; 13 taste Chinese medicines share, and play effect of promoting blood circulation to remove blood stasis, eliminating stagnation, pain relieving, heat-clearing and toxic substances removing altogether.
The Chinese medicine composition for the treatment of cyclomastopathy of the present invention, formulated according to theory of Chinese medical science, promoting blood circulation to remove blood stasis, eliminating stagnation, pain relieving, heat-clearing and toxic substances removing, each taste Chinese medicine combines according to monarch, plays maximum drug effect, Chinese medicine preparation, toxic and side effects is little, and cost is low, treating both the principal and secondary aspects of a disease.
Detailed description of the invention
Embodiment 1
Treat a Chinese medicine composition for cyclomastopathy, be made up of (every part of 1g) according to weight fraction following component:
Radix Curcumae 45 parts, Herba Leonuri 45 parts, Cortex Moutan 45 parts, Sanguis Draxonis 45 parts, Lignum Dalbergiae Odoriferae 45 parts, Rhizoma Arisaematis 25 parts, Rhizoma Typhonii 25 parts, Rhizoma Dioscoreae Bulbiferae 25 parts, Herba Ardisiae Japonicae 25 parts, 25 parts, Rhizoma Curcumae Longae, Rhizoma Polygoni Cuspidati 5 parts, Rhizoma Osmundae 5 parts, Cornu Saigae Tataricae 5.
Embodiment 2
Treat a Chinese medicine composition for cyclomastopathy, be made up of (every part of 1g) according to weight fraction following component:
Radix Curcumae 50 parts, Herba Leonuri 50 parts, Cortex Moutan 50 parts, Sanguis Draxonis 50 parts, Lignum Dalbergiae Odoriferae 50 parts, Rhizoma Arisaematis 30 parts, Rhizoma Typhonii 30 parts, Rhizoma Dioscoreae Bulbiferae 30 parts, Herba Ardisiae Japonicae 30 parts, 30 parts, Rhizoma Curcumae Longae, Rhizoma Polygoni Cuspidati 10 parts, Rhizoma Osmundae 10 parts, Cornu Saigae Tataricae 10.
Embodiment 3
Treat a Chinese medicine composition for cyclomastopathy, be made up of (every part of 1g) according to weight fraction following component:
Radix Curcumae 55 parts, Herba Leonuri 55 parts, Cortex Moutan 55 parts, Sanguis Draxonis 55 parts, Lignum Dalbergiae Odoriferae 55 parts, Rhizoma Arisaematis 35 parts, Rhizoma Typhonii 35 parts, Rhizoma Dioscoreae Bulbiferae 35 parts, Herba Ardisiae Japonicae 35 parts, 35 parts, Rhizoma Curcumae Longae, Rhizoma Polygoni Cuspidati 15 parts, Rhizoma Osmundae 15 parts, Cornu Saigae Tataricae 15.
Experimental example:
2008-2011, treats 25 routine cyclomastopathy patients altogether, wherein: sick 10 examples of mammary gland cystic cyclomastopathy, Cystic hyperplasia breast 6 example, mastalgia 9 example.
Therapeutic Method: the Chinese medicine composition of embodiment 2 routinely technique makes decoction, every day 1 dose, every day 2 times, 2 months is 1 course for the treatment of, continuously 2 courses for the treatment of of treatment.
Criterion of therapeutical effect
" the disease of tcm Standardization of diagnosis and curative effect " issued with reference to State Administration of Traditional Chinese Medicine is formulated.
1. fully recover: distending pain of the breast and lump disappear, take the photograph sheet inspection in conjunction with breast molybdenum target and confirm the disappearance of cyclomastopathy sign.Within after drug withdrawal 3 months, do not recur.
2. effective: distending pain of the breast disappears, and lump maximum gauge reduces more than 50%, breast molybdenum target is taken the photograph sheet inspection and is confirmed that cyclomastopathy tuberosity reduces or hypertrophy gland density alleviates and conforms to clinical.
3. effective: distending pain of the breast alleviates, physical palpation mass reduction, but not as good as 50%, breast molybdenum target is taken the photograph sheet inspection and is confirmed that cyclomastopathy takes a turn for the better, and substantially conforms to palpation with clinical symptoms.
4. invalid: distending pain of the breast is not improved compared with before treatment with lump, and breast molybdenum target takes the photograph sheet inspection confirmation.
Through there being the observation of two courses for the treatment of, recovery from illness 21 example, effective 4 examples, effective 0 example, invalid 0 example.

Claims (2)

1. treat a Chinese medicine composition for cyclomastopathy, it is characterized in that being made up of according to parts by weight following component:
Radix Curcumae 45-55 part, Herba Leonuri 45-55 part, Cortex Moutan 45-55 part, Sanguis Draxonis 45-55 part, Lignum Dalbergiae Odoriferae 45-55 part, Rhizoma Arisaematis 25-35 part, Rhizoma Typhonii 25-35 part, Rhizoma Dioscoreae Bulbiferae 25-35 part, Herba Ardisiae Japonicae 25-35 part, Rhizoma Curcumae Longae 25-35 part, Rhizoma Polygoni Cuspidati 5-15 part, Rhizoma Osmundae 5-15 part, Cornu Saigae Tataricae 5-15.
2. the Chinese medicine composition for the treatment of cyclomastopathy according to claim 1, is characterized in that being made up of according to parts by weight following component:
Radix Curcumae 50 parts, Herba Leonuri 50 parts, Cortex Moutan 50 parts, Sanguis Draxonis 50 parts, Lignum Dalbergiae Odoriferae 50 parts, Rhizoma Arisaematis 30 parts, Rhizoma Typhonii 30 parts, Rhizoma Dioscoreae Bulbiferae 30 parts, Herba Ardisiae Japonicae 30 parts, 30 parts, Rhizoma Curcumae Longae, Rhizoma Polygoni Cuspidati 10 parts, Rhizoma Osmundae 10 parts, Cornu Saigae Tataricae 10.
CN201310718920.2A 2013-12-23 2013-12-23 A kind of Chinese medicine composition for the treatment of cyclomastopathy Expired - Fee Related CN103656530B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310718920.2A CN103656530B (en) 2013-12-23 2013-12-23 A kind of Chinese medicine composition for the treatment of cyclomastopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310718920.2A CN103656530B (en) 2013-12-23 2013-12-23 A kind of Chinese medicine composition for the treatment of cyclomastopathy

Publications (2)

Publication Number Publication Date
CN103656530A CN103656530A (en) 2014-03-26
CN103656530B true CN103656530B (en) 2015-08-19

Family

ID=50296088

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310718920.2A Expired - Fee Related CN103656530B (en) 2013-12-23 2013-12-23 A kind of Chinese medicine composition for the treatment of cyclomastopathy

Country Status (1)

Country Link
CN (1) CN103656530B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104208183A (en) * 2014-09-12 2014-12-17 广西中医药大学 Externally used Yao medicine composition for treating cystic hyperplasia of breasts and preparation method thereof
CN104547450A (en) * 2015-01-29 2015-04-29 刘春娟 Traditional Chinese medicine preparation for treating hyperplasia of mammary glands and preparation method thereof

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094957A (en) * 1993-06-07 1994-11-16 宫龙章 Xiaojianwan pill for eliminating hard masses
CN1511523A (en) * 2002-12-30 2004-07-14 红 张 New use of bergenin in treating chronic prostatitis and proliferative diseases
CN1899367A (en) * 2005-07-19 2007-01-24 中国中医研究院中药研究所 Carpet bugle extract, its preparing method, use and composite preparation
CN101024028A (en) * 2007-03-29 2007-08-29 神威药业有限公司 Medicine composition for treating mammary gland hyperplasia and its extracting preparing method
CN101049425A (en) * 2007-05-11 2007-10-10 张来祥 Precious medicines of dispersing accumulation of pathogen for treating breast-dripping wet
CN101130034A (en) * 2007-09-24 2008-02-27 北京艺信堂医药研究所 Traditional Chinese medicine composition for treating gland hyperplasia
CN101185711A (en) * 2006-11-15 2008-05-28 杨恩铭 Nucleus eliminating ointment special for treating hyperplasia of mammary glands
CN101229357A (en) * 2008-01-30 2008-07-30 胡永旺 Chinese traditional medicine for treating mammary glands hyperplasia
CN101966320A (en) * 2010-07-13 2011-02-09 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof
CN103006795A (en) * 2011-09-22 2013-04-03 林丽春 Bath traditional Chinese medicine powder for preventing and treating breast hyperplasia

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1094957A (en) * 1993-06-07 1994-11-16 宫龙章 Xiaojianwan pill for eliminating hard masses
CN1511523A (en) * 2002-12-30 2004-07-14 红 张 New use of bergenin in treating chronic prostatitis and proliferative diseases
CN1899367A (en) * 2005-07-19 2007-01-24 中国中医研究院中药研究所 Carpet bugle extract, its preparing method, use and composite preparation
CN101185711A (en) * 2006-11-15 2008-05-28 杨恩铭 Nucleus eliminating ointment special for treating hyperplasia of mammary glands
CN101024028A (en) * 2007-03-29 2007-08-29 神威药业有限公司 Medicine composition for treating mammary gland hyperplasia and its extracting preparing method
CN101049425A (en) * 2007-05-11 2007-10-10 张来祥 Precious medicines of dispersing accumulation of pathogen for treating breast-dripping wet
CN101130034A (en) * 2007-09-24 2008-02-27 北京艺信堂医药研究所 Traditional Chinese medicine composition for treating gland hyperplasia
CN101229357A (en) * 2008-01-30 2008-07-30 胡永旺 Chinese traditional medicine for treating mammary glands hyperplasia
CN101966320A (en) * 2010-07-13 2011-02-09 泰一和浦(北京)中医药研究院有限公司 Chinese medicinal composition for treating proliferation of mammary gland and preparation method thereof
CN103006795A (en) * 2011-09-22 2013-04-03 林丽春 Bath traditional Chinese medicine powder for preventing and treating breast hyperplasia

Also Published As

Publication number Publication date
CN103656530A (en) 2014-03-26

Similar Documents

Publication Publication Date Title
CN102362947B (en) Chinese medicine for treating cough
CN100556446C (en) The Chinese medicine of treatment hepatocarcinoma
CN103656530B (en) A kind of Chinese medicine composition for the treatment of cyclomastopathy
CN101700363B (en) Traditional Chinese medicine for curing chronic atrophic gastritis
CN103948860B (en) A kind of Chinese medicine composition treating cyclomastopathy and preparation method thereof
CN103536869B (en) A kind of Traditional Chinese drug mixture for the treatment of varicocele
CN105434972A (en) Traditional Chinese medicine composition for treating breast hyperplasia
CN102488784A (en) Traditional Chinese medicine composition for treating low back pain
CN105412426A (en) Traditional Chinese medicine for lowering blood pressure
CN104547736A (en) Medicine for treating goiter
CN102441094A (en) Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis
CN101983682A (en) Medicament for treating female climacteric metancholia
CN103735802A (en) Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN101983719A (en) Novel medicament for treating lung cancer
CN103751293A (en) Traditional Chinese medicinal composition for treating chronic nephritis
CN102908585B (en) One treats sciatica Chinese medicine
CN103721012A (en) Traditional Chinese medicine composition for treating hyperplasia of mammary glands
CN109758565B (en) Traditional Chinese medicine composition for externally treating spleen-stomach deficiency-cold type chronic gastritis by acupoint application and application thereof
CN1666756A (en) Pain-relieving navel-applied paste
CN105250641A (en) Traditional Chinese medicine composition for treating rheumatism
CN104524472A (en) Tumble acesodyne plaster
CN101979079A (en) Medicament for treating astriction
CN105521419A (en) Medicine for treating premenstrual acne
CN102078387A (en) Traditional Chinese medicine for treating fibroid and ovarian cyst
CN103893340A (en) Traditional Chinese medicine preparation for treating cold coagulation and blood stasis type oviduct obstructive infertility

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150819

Termination date: 20211223

CF01 Termination of patent right due to non-payment of annual fee